Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Shareholders' Equity

v3.23.1
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2021 $ 270,066   $ 24,708 $ 62,398 $ 188,064   $ (5,104)
Beginning Balance (in shares) at Dec. 31, 2021       8,077.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7,067       7,067    
Net change in debt securities (3,447)           (3,447)
Net change in debit valuation adjustments 261           261
Net change in derivatives (5,179)           (5,179)
Employee benefit plan adjustments 24           24
Net change in foreign currency translation adjustments 28           28
Dividends declared:              
Common (1,706)       (1,706)    
Preferred (467)       (467)    
Issuance of preferred stock 2,429   2,429        
Common stock issued under employee plans, net, and other 191     $ 220 (29)    
Common stock issued under employee plans, net, and other (in shares)       41.7      
Common stock repurchased (2,650)     $ (2,650)      
Common stock repurchased (in shares)       (57.4)      
Ending balance at Mar. 31, 2022 266,617   27,137 $ 59,968 192,929   (13,417)
Ending Balance (in shares) at Mar. 31, 2022       8,062.1      
Beginning balance at Dec. 31, 2021 $ 270,066   24,708 $ 62,398 188,064   (5,104)
Beginning Balance (in shares) at Dec. 31, 2021       8,077.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative adjustment for adoption of credit loss accounting standard Accounting Standards Update 2022-02 [Member]            
Ending balance at Dec. 31, 2022 $ 273,197 $ 184 28,397 $ 58,953 207,003 $ 184 (21,156)
Ending Balance (in shares) at Dec. 31, 2022       7,996.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,161       8,161    
Net change in debt securities 555           555
Net change in debit valuation adjustments 10           10
Net change in derivatives 2,042           2,042
Employee benefit plan adjustments 10           10
Net change in foreign currency translation adjustments 12           12
Dividends declared:              
Common (1,774)       (1,774)    
Preferred (505)       (505)    
Common stock issued under employee plans, net, and other 519     $ 526 (7)    
Common stock issued under employee plans, net, and other (in shares)       42.4      
Common stock repurchased (2,215)     $ (2,215)      
Common stock repurchased (in shares)       (66.8)      
Ending balance at Mar. 31, 2023 $ 280,196   $ 28,397 $ 57,264 $ 213,062   $ (18,527)
Ending Balance (in shares) at Mar. 31, 2023       7,972.4